1. Home
  2. GRFS vs ZWS Comparison

GRFS vs ZWS Comparison

Compare GRFS & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • ZWS
  • Stock Information
  • Founded
  • GRFS 1940
  • ZWS 1891
  • Country
  • GRFS Spain
  • ZWS United States
  • Employees
  • GRFS N/A
  • ZWS N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • ZWS Industrial Machinery/Components
  • Sector
  • GRFS Health Care
  • ZWS Industrials
  • Exchange
  • GRFS Nasdaq
  • ZWS Nasdaq
  • Market Cap
  • GRFS 7.2B
  • ZWS 5.9B
  • IPO Year
  • GRFS 2006
  • ZWS 2012
  • Fundamental
  • Price
  • GRFS $10.13
  • ZWS $46.02
  • Analyst Decision
  • GRFS Hold
  • ZWS Buy
  • Analyst Count
  • GRFS 1
  • ZWS 5
  • Target Price
  • GRFS $10.30
  • ZWS $40.00
  • AVG Volume (30 Days)
  • GRFS 794.7K
  • ZWS 827.7K
  • Earning Date
  • GRFS 01-01-0001
  • ZWS 10-28-2025
  • Dividend Yield
  • GRFS 1.41%
  • ZWS 0.78%
  • EPS Growth
  • GRFS 132.60
  • ZWS 30.58
  • EPS
  • GRFS 0.53
  • ZWS 1.01
  • Revenue
  • GRFS $8,744,226,659.00
  • ZWS $1,614,000,000.00
  • Revenue This Year
  • GRFS $6.00
  • ZWS $7.44
  • Revenue Next Year
  • GRFS $6.71
  • ZWS $4.10
  • P/E Ratio
  • GRFS $24.82
  • ZWS $45.68
  • Revenue Growth
  • GRFS 9.32
  • ZWS 4.74
  • 52 Week Low
  • GRFS $6.19
  • ZWS $27.74
  • 52 Week High
  • GRFS $11.14
  • ZWS $46.60
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 52.17
  • ZWS 61.96
  • Support Level
  • GRFS $9.57
  • ZWS $44.51
  • Resistance Level
  • GRFS $9.99
  • ZWS $46.60
  • Average True Range (ATR)
  • GRFS 0.18
  • ZWS 0.86
  • MACD
  • GRFS -0.05
  • ZWS -0.26
  • Stochastic Oscillator
  • GRFS 51.85
  • ZWS 73.64

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.

Share on Social Networks: